The Humanoid Robot Market Could Be Worth More Than $7 Trillion. Here Are 3 Stocks to Own.

Mobileye, Qualcomm and Tesla are presented as potential long-term ways to gain exposure to humanoid robotics, a market Morgan Stanley estimates could reach $7.5 trillion by 2050. Mobileye acquired Mentee for $900 million, with commercialization expected to begin in 2028; Qualcomm introduced its Dragonwing IQ10 robotics chipset, already used by Figure. Tesla expects to produce 20,000 Optimus robots per week by the end of next year, though the article emphasizes that the opportunity is speculative and requires a long investment horizon.

Analysis

The investable question is not the 2050 market estimate; it is who captures value before robots reach scale. Edge inference could make QCOM a useful component supplier as latency, connectivity, and power consumption matter in coordinated machines. But chip selection may be swappable: NVIDIA and other platforms can compete, and durable economics may accrue to software, system integration, or actuator suppliers rather than silicon. Verify design wins translate into production volumes and revenue before treating the robotics angle as material to QCOM.

MBLY’s opportunity is a transfer of autonomy and mapping capabilities into a new product category, but the acquisition adds integration and commercialization risk to a business still exposed to auto-program timing. The stated 2028 commercialization horizon makes near-term earnings impact difficult to underwrite without customer and unit-economics disclosures.

For TSLA, manufacturing capacity is an advantage only if customers value the product and factories can produce it economically. Repurposing capacity also has an opportunity cost if it displaces vehicle output. The contrarian point: the bottleneck is likely reliable task performance, safety, and customer ROI—not the theoretical size of the labor market. Near term, expect narrative-driven moves; over 1–3 months, look for customer deployments, production milestones, and segment disclosure. Over 6–18 months, adoption evidence matters more than announced capacity. No valuation or consensus data here supports chasing the theme.

Key Decisions for Investors

• No immediate thematic buy based on the long-dated TAM. Keep QCOM on a watchlist; add only after a disclosed robotics design win shows production volume or meaningful revenue contribution. Falsifier: robotics adoption fails to broaden beyond pilots or competing platforms take the socket.
• Treat MBLY as a higher-risk execution option, not yet a robotics earnings thesis. Reassess on evidence of Mentee integration, customer commitments, and commercialization economics; a delay to the stated 2028 path or worsening core auto outlook would weaken the case.
• For TSLA, do not capitalize announced robot capacity as demand. Monitor delivered units, task performance, customer economics, and any vehicle-capacity trade-off. Missed production milestones or continued lack of external demand would falsify the scale thesis.
• If robotics enthusiasm drives a sharp sector rerating without production evidence, consider trimming thematic exposure rather than extrapolating the market-size estimate; the missing data are realized unit economics, repeat orders, and customer payback.